RecruitingNCT06572995

Thoracic Fluid Content During Stabilization and Therapeutic De-escalation in Septic Shock

Assessment of Intra-thoracic Water by Bio Reactance During Stabilization and Therapeutic De-escalation in Septic Shock: A Prospective, Multicenter, Observational Study


Sponsor

University Hospital, Brest

Enrollment

50 participants

Start Date

Jun 1, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

In ICU, fluid challenge represents one of the cornerstones of hemodynamic care. However, fluid overload due to an excessive and/or inappropriate fluid administration could be associated with morbidity or mortality. Unfortunately, there is currently no continuous non-invasive devices to monitor fluid content at bedside. Bio reactance is a non-invasive, rapid and continuous technology developed in order to measure body fluid compartment. Monitoring devices functioning with such technology are promising to evaluate fluid overload in ICU.


Eligibility

Min Age: 18 YearsMax Age: 99 Years

Inclusion Criteria6

  • Adult (Age >18 years old)
  • Septic shock according to Sepsis-3 definition:
  • A suspected or confirmed infection
  • Persisting hypotension, despite adequate fluid resuscitation, requiring vasopressor to maintain a Mean Arterial Pressure (MAP) ≥ 65 mmHg
  • Lactate level > 2 mmol/l
  • Predictive ICU length of stay > 3 days

Exclusion Criteria5

  • Admission in ICU for more than 3 days
  • Refusal to participate
  • Moribund patients
  • Decision of therapeutic withdrawal
  • Curators

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(2)

Chu Brest

Brest, France

Hegp - Aphp

Paris, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06572995


Related Trials